INTERVIEWS

Guest: Dr. Rajesh Gade, MD   

Presenter: Neal Howard

Guest Bio: Raj started at DaVita Medical Group in 2008 as a hospitalist at Huntington Hospital, he then went on to become a lead hospitalist at Arcadia Methodist Hospital, and then to physician director for inpatient and high-risk programs in the Angelenos Community. He is a triple board certified in internal medicine, infectious diseases and critical care medicine. He is a proven leader whose extensive clinical experience is an asset to the many teams he will support. Raj has built and fostered strong relationships while serving in his many roles. In his spare time, he enjoys traveling and playing board games with his children.

Segment Overview: Dr. Rajesh Gade, MD, discusses key stats, misconceptions about the flu, and what physicians should keep in mind when speaking to patients about flu season. Know more at:  http://www.davitamedicalgroup.com

Guest: Deborah Norris, Ph.D.  

Presenter: Neal Howard

Guest Bio: Dr. Norris is Founder of The Mindfulness Center; and is the Founder and Director of the Psychobiology of Healing Program in the Department of Psychology at American University. Dr. Norris worked for 15 years as a health scientist specializing in neurobehavioral toxicology at the United States Environmental Protection Agency. In her practice, Dr. Norris integrates lifestyle elements of meditation, yoga, exercise, and relaxation therapy, tai chi, nutrition and herbalism for maximal health and happiness! A health scientist with over thirty-five years of experience, Dr. Norris teaches and conducts research in behavioral medicine, and other mind-body approaches to wellbeing.

Segment Overview: Deborah Norris, Ph.D., a neurobehavioral scientist, talks about her new book “In the Flow: Bridging the Science and Practice of Mindfulness” that explains in clear language how mindfulness relieves pain, inflammation and disease.

Guest: Dr. Mohammed Issa

Presenter: Neal Howard

Guest Bio: Dr. Mohammed Issa is an Instructor at Harvard Medical School with clinical appointments in the Departments of Anesthesiology, Perioperative and Pain Medicine, and Psychiatry. His recent academic work has focused on the relationship between chronic pain and addiction, with special interest in opioid use disorder, utilization of buprenorphine for chronic pain patients showing high-risk behaviors and genetics underlying addiction in chronic pain patients receiving opioid medications. Dr. Issa has been an active member of the scientific abstract and publication committees of the American Academy of Pain Medicine, North American Neuromodulation Society, and Massachusetts Society of Anesthesiologists. He has authored several book chapters, articles and abstracts in the areas of behavioral medicine, addiction and chronic pain.  

Segment Overview: Dr. Mohammed Issa, Medical Director, Pain Management Clinic, Brigham and Women’s Faulkner Hospital, discusses the important role of abuse-deterrent opioids in helping to curb the opioid epidemic.

Guest: Dr. Frankie Ann Holmes, MD

Presenter: Neal Howard

Guest Bio: Dr. Holmes is board certified in internal medicine and also medical oncology. My professional career has involved the treatment and research for the cure of breast cancer. At MD Anderson, I completed my cancer training and joined the Faculty of Breast Medical Oncology. At MD Anderson, I performed the first clinical trial of paclitaxel (Taxol) resulting in approval for breast cancer. After 15 years at MD Anderson, I joined Texas Oncology/The US Oncology Network and the Breast Cancer Research Committee. I was the principal investigator for the clinical trial that led to the approval of pegfilgrastim (Neulasta) for prevention of low white blood cells from chemotherapy. I have continued as an active member of the Breast Cancer Research Committee with The US Oncology Network.   

Segment Overview: Returning guest Dr. Frankie Ann Holmes, MD further discusses the recently FDA approved NERLYNX treatment for early stage HER2-positive breast cancer.  She also talks about the most uncommon symptoms of breast cancer that patients and clinicians might overlook and the future of breast cancer treatment.

Guest: Dr. Melody Caramins

Presenter: Tabetha Moreto

Guest Bio: Dr. Melody Caramins is the Chair of The Royal College of Pathologists of Australasia’s genetics advisory committee. As an ambassador for Pathology Awareness Australia and Chair of The Royal College of Pathologists of Australasia’s genetics advisory committee, Dr. Caramins is an active advocate for greater access to genetic testing, and for greater inclusion of genetics in mainstream medicine.She is also is the National Director of Genetics at Primary Health Care where she has overall responsibility for the supervision and coordination of genetic testing, and oversees the introduction of all new genetic tests.  With over 20 years of experience in medicine and pathology, Dr. Caramins is a nationally recognised expert in the field of genetics, holding both medical and scientific specialist qualifications.

Segment Overview: In today’s interview, Dr. Caramins discusses about the new BRCA gene tests that will soon be offered for free to people especially women who have a family history of breast and ovarian cancer. She also talks about preventive measures to take for those at risk and available treatment options for those who are already diagnosed with these cancers.

Guest: Professor Huyen Tran

Presenter: Tabetha Moreto

Guest Bio: Professor Huyen Tran is the is the head of the Haemostasis Thrombosis Unit, The Alfred Hospital Chair, Clinical Trials Group, Thrombosis & Haemostasis Society of Australia and New Zealand or THANZ. He is an experienced Associate Professor with a demonstrated history of working in the higher education industry. Skilled in Clinical Research, Medical Education, Epidemiology, Thrombosis, and Medicine. Strong education professional graduated from Monash University. His focus is on clinical research in haematology with particular interests in thrombotic, bleeding and platelet disorders, and obstetrics haematology.

Segment Overview: In today’s interview, Dr. Huyen Tran discusses about the nature of a condition called Atrial Fibrillation (or Afib) along with its causes and what can be done to prevent it. He also talks about the correlation between Afib and stroke.

Guest: Malaz Boustani, M.D., MPH

Presenter: Neal Howard

Guest Bio: Malaz Boustani, M.D., MPH, conducts clinical research to improve the care of older adults who suffer from diseases associated with the aging brain. He works to improve every aspect of the care of older adults with dementia and delirium. He is the director and cofounder of the Eskenazi Health Center Healthy Aging Brain Center (HABC), where he leads a team of geriatricians and neurologists, as well as an expert staff in social work, nursing and neuropsychology, in providing care. As a physician, researcher and teacher, Dr. Boustani is an associate professor of medicine at the Indiana University School of Medicine. In 2005, he was awarded the prestigious Paul B. Beeson Leadership Award in Geriatric Medicine from the John A. Hartford Foundation and the National Institute on Aging.

Segment Overview: In this segment, Dr. Malaz Boustani discusses the Eskenazi Health Richard M. Fairbanks Burn Center and the Sandra Eskenazi Center for Brain Care Innovation, two services of the Eskenazi Health Center in Indianapolis, the first center of its kind in the United States to combine pioneering research and clinical care, yielding faster and more effective outcomes for the patient and caregiver.

Guest: Dr. Andrew Greenspan, M.D.

Presenter: Neal Howard

Guest Bio: Andrew Greenspan, MD is the Vice President for U.S. Medical Affairs, Janssen Immunology. based in Horsham, Pennsylvania. He is responsible for overseeing the Medical Affairs activities supporting REMICADE®, SIMPONI®, SIMPONI ARIA®, STELARA®, and TREMFYA®, including the execution of all Post-Marketing Requirements and Post-Marketing Commitments.
Andy joined Johnson & Johnson in 2003 with progressively increasing responsibilities, working across both Medical Affairs and R&D in Neuroscience, Immunology, and Oncology.
He has led Phase 1 through 4 clinical studies and has co-authored over 30 peer-reviewed journal articles.
Andy graduated Magna Cum Laude from Columbia University, where he studied Psychology and earned his medical degree from Harvard Medical School. He completed his residency training in internal medicine at New York Hospital/Weill Cornell Medical College.

Segment Overview: Dr. Andrew Greenspan discusses the recent FDA approval of STELARA® (ustekinumab) for adolescents (12 years of age or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Guest: Dr. Charles S. Fuchs, M.D.

Presenter: Neal Howard

Guest Bio: Charles S. Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017. An internationally recognized expert in gastrointestinal cancers and cancer epidemiology, Dr. Fuchs was previously professor of medicine at Harvard Medical School and chief of the gastrointestinal oncology division and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute. Dr. Fuchs received his medical degree from Harvard Medical School in 1986. He completed his medical residency at Brigham and Women’s Hospital, where he also served as chief medical resident and completed his medical oncology fellowship at Dana-Farber Cancer Institute. In 1994, he received his M.P.H. from Harvard School of Public Health.

Segment Overview: Dr. Charles S. Fuchs discusses the recent FDA approval of KEYTRUDA (pembrolizumab) for patients with advanced gastric cancer that have received 2 or more lines of chemotherapy, and what this means for patients, doctors, and caregivers.

Guest: Dr. Bob Carter

Presenter: Neal Howard

Guest Bio: Bob S. Carter, MD, is a board-certified neurosurgeon who specializes in brain tumors, vascular lesions and complex intracranial surgery, including cerebral bypass and aneurysm surgery. Dr. Carter co-leads MGH’s brain tumor program, which brings together the efforts of over 100 faculty and staff who are focused on brain tumor clinical care, research and education. He is the Chair of the Department of Neurosurgery at MGH and Visiting Professor at Harvard Medical School. Dr. Carter is extensively published and his work has been cited more than 15,000 times in the scientific literature. He lectures both nationally and internationally on neurosurgery topics, and is an editorial board member for the Journal of Neurosurgery and editorial advisory board member of Neurosurgery.

Segment Overview: Dr. Bob Carter discusses what is coming down the pike in neurosurgery, brain cancer treatment, and groundbreaking research.